Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling.
Horigome E, Fujieda M, Handa T, Katayama A, Ito M, Ichihara A, Tanaka D, Gombodorj N, Yoshiyama S, Yamane A, Yamada K, Horiguchi J, Shinozuka K, Oyama T, Nishiyama M, Rokudai S.
Horigome E, et al. Among authors: rokudai s.
Oncotarget. 2018 Oct 2;9(77):34554-34566. doi: 10.18632/oncotarget.26177. eCollection 2018 Oct 2.
Oncotarget. 2018.
PMID: 30349649
Free PMC article.